Get ready for another wave of new and improved OTCs

Check out important updates from the FDA for the week of April 15.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.

The antibiotic was approved to treat Staphylococcus aureas bacteremia, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.